| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2004 | CN1147317C Combination of tyrosine kinase inhibitor and chemical castration and its use in pharmaceutical production |
| 04/28/2004 | CN1147303C Application of Breviscapine in preparing medicine |
| 04/28/2004 | CN1147302C Medicinal bai of bolbstemmatoside B for preventing and controlling human and animal virus disease |
| 04/28/2004 | CN1147301C Progestin therapy with controlled bleeding |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CN1147299C Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/28/2004 | CN1147298C Prevention and curing agent for hepatitis C |
| 04/28/2004 | CN1147297C Novel aesculetin derivatives and pharmaceutical composition |
| 04/28/2004 | CN1147296C Preparation method of medicine for resisting ischemic and brain trauma using taurine |
| 04/28/2004 | CN1147295C Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof and its preparation |
| 04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
| 04/28/2004 | CN1147292C Double capsule for the administration of active principles in multiple therepies |
| 04/28/2004 | CN1147289C Method and compositions for stabilizing acetylcholine compositions |
| 04/28/2004 | CN1147282C Molecule implanting needle |
| 04/28/2004 | CN1147232C Antiparasitic formulations |
| 04/27/2004 | US6727401 Occlusive backing layer; antifungal fluconazole, terbinafine, clotrimazole, miconazole and ketoconazole, salts or mixtures thereof; nail infections |
| 04/27/2004 | US6727392 Such as 4b(s)-benzyl-7(s)-hydroxy-7(s)-(3,3,3-trifluoropropyl)4,5,6,7,8,8a(r),9,10 -octahydro-phenanthrene-2-carboxylic acid (2-methyl-pyridin-3-ylmethyl)-amide via catalytic reduction; transcription factors |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727363 From toluene/diethyl ether mixture; recovering, drying |
| 04/27/2004 | US6727352 Methods of making macrolides |
| 04/27/2004 | US6727347 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 04/27/2004 | US6727288 Method for treating bone fracture |
| 04/27/2004 | US6727287 Comprising less than 10% by weight of a toluene sulfonamide and a pharmaceutically acceptable carrier |
| 04/27/2004 | US6727286 Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 04/27/2004 | US6727285 Administering to blood dialysis system |
| 04/27/2004 | US6727284 Delivering solution of dichloroacetae for therapy and prophyalxis of poor cardiac function following surgery |
| 04/27/2004 | US6727283 Used to prepare an aqueous solution of sertraline; therapy and prophylaxis of depression, anorexia, chemical dependencies, anxiety-related disorders, premature ejaculation, cancer and post myocardial infarction |
| 04/27/2004 | US6727282 Human immunodeficiency virus (hiv) or aids treatment |
| 04/27/2004 | US6727281 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727278 Pharmaceutically active agents that impede amyloid formation in vivo |
| 04/27/2004 | US6727276 Epothilone derivatives for the treatment of refractory tumors |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727274 Use in treating conditions in which 5-ht6 receptors are involved such as anxiety, depression, schizophrenia, alzheimer's disease, stress-related disease, nervous system disorders; use in performing positron emission tomography |
| 04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
| 04/27/2004 | US6727272 Leflunomide analogs for treating rheumatoid arthritis |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727268 Cyclooxygenase inhibitors; antipyretic, analgesic, antiinflammatory, and anticarcinogenic agents |
| 04/27/2004 | US6727263 Serotonine reuptake inhibitor; antidepressants; side effect reduction |
| 04/27/2004 | US6727262 Dichlorinated heterocyclic compounds and methods of synthesis |
| 04/27/2004 | US6727261 Pyrido[2,1-A]Isoquinoline derivatives |
| 04/27/2004 | US6727260 Using compounds capable of inhibiting the activity of a proton-gated cation channel in therapy or aleviation of diseases or disorders associated with, or mediated by a drop in extracellular ph |
| 04/27/2004 | US6727259 Remedial agent for neural degeneration |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727254 8-(bis-(phenyl) methyl)-3-heteroaryl-8-azabicyclo-(3.2.1)octan-3-ols and derivatives, useful in treating pain, anxiety, cough, asthma, depresion and alcohol abuse |
| 04/27/2004 | US6727253 Use of a topo ii catalytic nhibitor such as the bisdioxopiperazine icrf-187, a quinoline, aclarubicin, and an acridine. |
| 04/27/2004 | US6727252 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
| 04/27/2004 | US6727245 Heterobicyclic derivatives |
| 04/27/2004 | US6727244 Mammalian metabolites of a tachykinin receptor antagonist |
| 04/27/2004 | US6727243 Solid solution dissolved in a polymer |
| 04/27/2004 | US6727242 Pharmacological treatment for sleep apnea |
| 04/27/2004 | US6727241 Inhibit the binding of various chemokines, such as mip-1 alpha and rantes, to the ccr1 receptor |
| 04/27/2004 | US6727240 Methods for preventing HIV-1 or HIV-2 infection |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727238 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 04/27/2004 | US6727235 Synergistic compositions for the selective control of tumor tissue |
| 04/27/2004 | US6727233 Administering 1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)ethane-1,1-bisphosphonic acid |
| 04/27/2004 | US6727231 Effective to improve one or more of the symptoms of autistic disorder |
| 04/27/2004 | US6727228 Mixture containing pesticide and stabilizer |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727081 Microorganism isolated from chinese elm (Ulmus sp.) and process for preparing exopolysaccharides by employing the microorganism |
| 04/27/2004 | US6727064 Antiinflammatory agents; anticarcinogenic agents |
| 04/27/2004 | US6727059 Method for controlling the fidelity and processivity of reverse transcriptase by incorporation and polymerization of nucleotide analogs accepted as substrates for the reverse transcription reaction without blocking its elongation |
| 04/27/2004 | US6726939 Composition and method for reducing blood pressure, alleviating or eliminating angina pectoris and headaches, and enhancing skin and hair |
| 04/27/2004 | US6726938 Fagopyrum cymosum (Trev.) Meisn composition, method to prepare and analyze the same and uses thereof |
| 04/27/2004 | US6726931 Process for preparing oral sustained-release formulation of felodipine |
| 04/27/2004 | US6726929 Pharmaceutical mixture comprising a profen |
| 04/27/2004 | US6726928 Process for preparing solid dosage forms for unpalatable pharmaceuticals |
| 04/27/2004 | US6726927 Comprises core granulation formed by dry mixing drug or its salt with alkaline substance and pharmaceutical excipients which can be quantitatively filled into an empty hard gelatin capsule; provides gastrointestinal cytoprotective benefit |
| 04/27/2004 | US6726926 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/27/2004 | US6726925 Bi-layer membrane comprising phospholipid and lysolipid; drug delivery, medical diagnosis |
| 04/27/2004 | US6726924 Oral liposomal delivery system |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726922 Process and composition for temporarily suppressing pain |
| 04/27/2004 | US6726919 For inducing or maintaining anesthesia or sedation in a patient |
| 04/27/2004 | US6726918 Implanting bioerodible particle comprising steroidal antiinflammatory agent and polymer that delivers dexamethasone to vitreous; ophthalmology; uveitis, vision defects |
| 04/27/2004 | US6726912 Papillomavirus polyprotein constructs |
| 04/27/2004 | US6726908 Comprising amoxycillin and potassium clavulanate in a ratio of 10:1 to 20:1 and used in the emperic treatment of infections potentially caused by drug-resistant streptoccocus pneumoniae; respiratory system disorders |
| 04/27/2004 | US6726906 Orally administered poly(n,n-di(2,3-dihydroxypropyl) allylamine)hydrochloride and tetrahydrolipstatin lipase inhibitor; hypertriglyceridemia; side effect reduction |
| 04/27/2004 | US6726905 Lowering serum phosphate |
| 04/27/2004 | US6726896 Stool marker |
| 04/27/2004 | US6726895 Tumor radiotherapy |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | US6726677 Stabilized tissue penetrating catheters |
| 04/27/2004 | CA2317530C Dysuria remedies |
| 04/27/2004 | CA2299400C Method for treating disease-related or drug-induced dyskinesias |
| 04/27/2004 | CA2290974C Solubilized sertraline compositions |
| 04/27/2004 | CA2271750C Prolonged anesthesia in joints and body spaces |
| 04/27/2004 | CA2256017C .beta.,.beta.-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a |
| 04/27/2004 | CA2187394C Diabetic nutritional product having controlled absorption of carbohydrate |
| 04/27/2004 | CA2177732C Antisense oligonucleotides having tumorigenicity-inhibiting activity |
| 04/27/2004 | CA2140368C (3r,4r)-.delta.6-tetrahydrocannabinol-7-oic acids |
| 04/27/2004 | CA2118929C (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |